RT Journal Article
SR Electronic
T1 Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma: a phase 1b study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003518
DO 10.1136/jitc-2021-003518
VO 10
IS 1
A1 Yoshikawa, Akie Kimura
A1 Yamaguchi, Kensei
A1 Muro, Kei
A1 Takashima, Atsuo
A1 Ichimura, Takashi
A1 Sakai, Daisuke
A1 Kadowaki, Shigenori
A1 Chin, Keisho
A1 Kudo, Toshihiro
A1 Mitani, Seiichiro
A1 Kitano, Shigehisa
A1 Thai, Dung
A1 Zavodovskaya, Marianna
A1 Liu, JieJane
A1 Boku, Narikazu
A1 Satoh, Taroh
YR 2022
UL http://jitc.bmj.com/content/10/1/e003518.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.